THE CURRENT STATE OF ANTIBIOTIC RESISTANCE AND THE COMPOSITION OF PATHOGENS OF URINARY TRACT INFECTIONS IN PREGNANT WOMEN

Introduction. The main treatment component of asymptomatic bacteriuria, acute cystitis and pyelonephritis in pregnant women is antibiotic therapy, which in many patients is prescribed empirically. For successful selection of the drug, it is necessary to know both the structure of pathogens and the current profile of their antibiotic resistance.

Purpose of research. The study of species composition and resistance to antibiotics of bacteria that cause urinary tract infections (UTIs) in pregnant women in the Moscow Region

Materials and methods. The study included 104 pregnant women with uncomplicated UTIs who were observed and treated at the Lapino Clinical Hospital between 2016 and 2017. The material for bacteriological studies was the midstream portion of urine or urine collected by a catheter.

Results. 90 patients had asymptomatic bacteriuria, 10 had acute cystitis, and 4 had acute gestational pyelonephritis. The structure of the pathogens of UTI is presented: E. coli, Enterococcus faecalis, Klebsiella pneumoniae, Proteus spp., Staphylococcus spp., Streptococcus spp., Enterobacter cloacae. The most frequently detected pathogens were E. coli (67.3%) and E. faecalis (50%). Resistance rate of E.coli strains more than 20% was detected to ampicillin (36.4%), amoxicillin / clavulanate (23.2%), trimethoprim / sulfamethoxazole (27.4%), nalidixic acid (20.7%), cephalosporins 2 and 3 generation (respectively, 25.7% and 24.3%). Resistance rate more than 20% in Enterobacteriaceae family strains was detected to trimethoprim/sulfamethoxazole (24.4%), nalidixic acid (20.7%), cephalosporins 2 generations (21.7%). Antibiotic resistance of E.coli and other Enterobacteriaceae family taxons less than 10% was noted only with respect to carbapenems (0%) and fosfomycin (1.5% and 3.5%, respectively).

Conclusions. It is expedient to use the obtained data on the composition and sensitivity profile of uropathogens in UTIs in pregnant women when choosing starting empirical antibiotic therapy. 

Disclosure: The study did not have sponsorship. The authors have declared no conflicts of interest.

1. Hooton TM. Uncomplicated urinary tract infection. New Engl J Med. 2012; 366:1028-10-37 DOI: 10.1056/ NEJMcp1104429

2. Kahlmeter G, ECO.SENS. An international survey on the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother. 2003; 51:69-76. DOI: 10.1056/NEJMcp1104429

3. Nicole L. Epidemiology of urinary tract infections. Infect Med 2001; 18:153-162.

4. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990; 80:31-333 PMID: 2305919

5. MacLean AB. Urinary tract infection in pregnancy. Int J Antimicrob Agents. 2001; 17:273-277. DOI: 10.1016/ S0924-8579(00)00354-X

6. Palagin IS, Sukhorukova MV, Dehnich AV, Eidelshtein MV, Shevelev AN, Grinev AV, Perepanova TS, Kozlov RS, research group «DARMIS». The current state of antibiotic resistance of pathogens of community-acquired infections of the urinary tract in Russia: the results of the DARMIS study (2010-2011). Klin mikrobiol i antimikrob khimioter [Clinical microbiology and antimicrobial chemotherapy]. 2013;(4):98-102. (In Russ.)

7. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29(4):745-758. DOI: 10.1086/520427

8. Bonkat G, Pickard R, Bartoleƫ R, Cai T, Bruyère F, Geerlings SE, Köves B, Wagenlehner F. Guidelines Associates: Pilatz A, Pradere B, VeeraƩ erapillay R. EAU Guidelines on Urological InfecƟ ons. ISBN 978-94-92671-01-1. hƩ p:// uroweb.org/wp-content/uploads/EAU-Guidelines-onUrological-InfecƟ ons-2018-large-text.pdf

9. Matuschek E,Brown D F Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol and Infect. 2014;20(4):255- 266. DOI: 10.1111/1469-0691.12373